Cell Signaling Technology Inc

Cell Signaling Technology Inc. is a privately held, family-owned company based in Danvers, Massachusetts. Founded in 1999 by research scientists, CST employs 686 people and generates approximately $40 million in annual revenue. CST is dedicated to developing high-quality research products, particularly antibodies, for other researchers in the field of applied systems biology, with a focus on cancer research. Their antibodies are rigorously validated for multiple applications by Ph.D. level scientists, ensuring researchers receive reliable and consistent results. A key differentiator for CST is the personalized technical support provided by the same scientists who developed the antibodies. This direct access to expert knowledge enables researchers to overcome challenges, refine their methods, and achieve optimal outcomes. To learn more about CST's products and services, visit their website at cellsignal.com.